DPP4 and metabolic dysfunction-associated steatotic liver disease: Finally, in the whole study population (n = 178), higher plasma DPP4 activity independently associated to the diagnosis of NAFLD with an OR: 3.504 (95% CI 1.20–10.21, p = 0.022) regardless of potential confounders, as shown in the multivariate logistic regression analysis (Table 5).